Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 13, 2014 03:01 ET | Source: G2B Pharma Inc.

G2B Pharma Receives Project Financing From Sosei and Right to In-license Nasal Delivery Technologies From SNBL

SAN FRANCISCO, Aug. 13, 2014 (GLOBE NEWSWIRE) -- G2B Pharma Inc. ('G2B' Chairman and CEO, Nigel Ten Fleming PhD, San Francisco, USA) announces the signing of an agreement with Sosei Group...
September 10, 2013 09:30 ET | Source: G2B Pharma Inc.

Novel Nasal Epinephrine Shows Comparable Absorption to EpiPen(R) in a Feasibility Study

SAN FRANCISCO, Sept. 10, 2013 (GLOBE NEWSWIRE) -- Shin Nippon Biomedical Laboratories, Ltd. ('SNBL' Chairman and CEO, Ryoichi Nagata MD PhD FFPM, Tokyo, Japan) and G2B Pharma Inc. ('G2B' Chairman and...